These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 9576385)
1. A polymerase chain reaction for the diagnosis of Haemophilus influenzae type b disease in children and its evaluation during a vaccine trial. Hassan-King M; Adegbola R; Baldeh I; Mulholland K; Omosigho C; Oparaugo A; Usen S; Palmer A; Schneider G; Secka O; Weber M; Greenwood B Pediatr Infect Dis J; 1998 Apr; 17(4):309-12. PubMed ID: 9576385 [TBL] [Abstract][Full Text] [Related]
2. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine [corrected] for prevention of pneumonia and meningitis in Gambian infants. Mulholland K; Hilton S; Adegbola R; Usen S; Oparaugo A; Omosigho C; Weber M; Palmer A; Schneider G; Jobe K; Lahai G; Jaffar S; Secka O; Lin K; Ethevenaux C; Greenwood B Lancet; 1997 Apr; 349(9060):1191-7. PubMed ID: 9130939 [TBL] [Abstract][Full Text] [Related]
3. Rapid detection of Haemophilus influenzae type b in Bangladeshi children with pneumonia and meningitis by PCR and analysis of antimicrobial resistance. Shoma S; Rahman M; Yasmin M J Health Popul Nutr; 2001 Dec; 19(4):268-74. PubMed ID: 11855348 [TBL] [Abstract][Full Text] [Related]
4. Incidences of vaccine-preventable Haemophilus influenzae type b pneumonia and meningitis in Indonesian children: hamlet-randomised vaccine-probe trial. Gessner BD; Sutanto A; Linehan M; Djelantik IG; Fletcher T; Gerudug IK; Ingerani ; Mercer D; Moniaga V; Moulton LH; Moulton LH; Mulholland K; Nelson C; Soemohardjo S; Steinhoff M; Widjaya A; Stoeckel P; Maynard J; Arjoso S Lancet; 2005 Jan 1-7; 365(9453):43-52. PubMed ID: 15643700 [TBL] [Abstract][Full Text] [Related]
5. An evaluation of the safety and immunogenicity of a five-component acellular pertussis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Lee CY; Thipphawong J; Huang LM; Lee PI; Chiu HH; Lin W; Debois H; Harrison D; Xie F; Barreto L Pediatrics; 1999 Jan; 103(1):25-30. PubMed ID: 9917435 [TBL] [Abstract][Full Text] [Related]
6. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study. Adegbola RA; Secka O; Lahai G; Lloyd-Evans N; Njie A; Usen S; Oluwalana C; Obaro S; Weber M; Corrah T; Mulholland K; McAdam K; Greenwood B; Milligan PJ Lancet; 2005 Jul 9-15; 366(9480):144-50. PubMed ID: 16005337 [TBL] [Abstract][Full Text] [Related]
7. Detection of antigenuria for diagnosis of invasive Haemophilus influenzae type b disease. Saha SK; Baqui AH; El Areefin S; Qazi S; Billal DS; Islam M; Roy E; Ruhulamin M; Black RE; Santosham M Ann Trop Paediatr; 2006 Dec; 26(4):329-36. PubMed ID: 17132298 [TBL] [Abstract][Full Text] [Related]
8. Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine. Sow SO; Diallo S; Campbell JD; Tapia MD; Keita T; Keita MM; Murray P; Kotloff KL; Levine MM Pediatr Infect Dis J; 2005 Jun; 24(6):533-7. PubMed ID: 15933564 [TBL] [Abstract][Full Text] [Related]
9. Haemophilus influenzae type-b and non-b-type invasive diseases in urban children (<5years) of Bangladesh: implications for therapy and vaccination. Rahman M; Hossain S; Baqui AH; Shoma S; Rashid H; Nahar N; Zaman MK; Khatun F J Infect; 2008 Mar; 56(3):191-6. PubMed ID: 18280571 [TBL] [Abstract][Full Text] [Related]
10. The Gambian Haemophilus influenzae type b vaccine trial: what does it tell us about the burden of Haemophilus influenzae type b disease? Mulholland EK; Adegbola RA Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S123-5. PubMed ID: 9781744 [TBL] [Abstract][Full Text] [Related]
11. Vaccination with a Haemophilus influenzae type b conjugate vaccine reduces oropharyngeal carriage of H. influenzae type b among Gambian children. Adegbola RA; Mulholland EK; Secka O; Jaffar S; Greenwood BM J Infect Dis; 1998 Jun; 177(6):1758-61. PubMed ID: 9607866 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations. Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487 [TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216 [TBL] [Abstract][Full Text] [Related]
14. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens. Lagos R; Valenzuela MT; Levine OS; Losonsky GA; Erazo A; Wasserman SS; Levine MM Lancet; 1998 May; 351(9114):1472-6. PubMed ID: 9605803 [TBL] [Abstract][Full Text] [Related]
15. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines. Schmitt HJ; von Kries R; Hassenpflug B; Hermann M; Siedler A; Niessing W; Clemens R; Weil J Pediatr Infect Dis J; 2001 Aug; 20(8):767-74. PubMed ID: 11734739 [TBL] [Abstract][Full Text] [Related]
16. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile. Levine OS; Ortiz E; Contreras R; Lagos R; Vial P; Misraji A; Ferreccio C; Espinoza C; Adlerstein L; Herrera P Am J Epidemiol; 1993 Jun; 137(11):1221-8. PubMed ID: 8322763 [TBL] [Abstract][Full Text] [Related]
17. A combined Haemophilus influenzae type B Neisseria meningitidis serogroup C tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when coadministered with diphtheria, tetanus, acellular pertussis hepatitis B-inactivated poliovirus at 3, 5 and 11 months of age: results of an open, randomized, controlled study. Vesikari T; Forstén A; Desole MG; Ferrera G; Caubet M; Mesaros N; Boutriau D Pediatr Infect Dis J; 2013 May; 32(5):521-9. PubMed ID: 23190785 [TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a Haemophilus influenzae type b-tetanus conjugate vaccine when administered separately or in combined vaccines for primary immunization in two consecutive national schedules in Turkey. Yüksel N; Beyazova U; Balci IF; Aksakal FN; Camurdan AD; Sahin F; Rota S Int J Infect Dis; 2012 May; 16(5):e354-7. PubMed ID: 22387144 [TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of two Haemophilus influenzae type b polysaccharide-tetanus toxoid conjugate vaccines (PRP-T) given with diphtheria-tetanus-pertussis vaccine to young Papua New Guinean children. Lehmann D; Kakazo M; Saleu G; Taime J; Javati A; Namuigi P; Alpers MP; Wegmüller B; Zellmeyer M; Fürer E; Que JU; Herzog C P N G Med J; 2001; 44(1-2):6-16. PubMed ID: 12418673 [TBL] [Abstract][Full Text] [Related]
20. Antigenuria in Gambian infants following immunization with a Haemophilus influenzae type b polyribosylribitol phosphate-tetanus toxoid protein conjugate (PRP-T) vaccine. Adegbola RA; Leach A; Mulholland K; Hilton S; Demba E; Jaffar S; Greenwood BM Diagn Microbiol Infect Dis; 1998 Sep; 32(1):15-9. PubMed ID: 9791752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]